Related references
Note: Only part of the references are listed.Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy
Shaloam Dasari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Interaction of Masitinib with Organic Cation Transporters
Saliha Harrach et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cisplatin Mouse Models: Treatment, Toxicity and Translatability
Martina Perse
BIOMEDICINES (2021)
Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice
Kevin M. Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer
Kelly R. McMahon et al.
JAMA NETWORK OPEN (2020)
C57BL/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury
Sophia M. Sears et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2020)
Multiple binding sites in organic cation transporters require sophisticated procedures to identify interactions of novel drugs
Hermann Koepsell
BIOLOGICAL CHEMISTRY (2019)
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection
Anna Hucke et al.
ARCHIVES OF TOXICOLOGY (2019)
Protein Abundance of Clinically Relevant Drug Transporters in The Human Kidneys
Stefan Oswald et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment
Nathan P. Staff et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2019)
Rat Organic Cation Transporter 1 Contains Three Binding Sites for Substrate 1-Methyl-4-phenylpyridinium per Monomer
Thorsten Keller et al.
MOLECULAR PHARMACOLOGY (2019)
Global Transcriptomic Profile of Dorsal Root Ganglion and Physiological Correlates of Cisplatin-Induced Peripheral Neuropathy
Sherrie Lessans et al.
NURSING RESEARCH (2019)
Perturbation of Iron Metabolism by Cisplatin through Inhibition of Iron Regulatory Protein 2
Masaki Miyazawa et al.
CELL CHEMICAL BIOLOGY (2019)
The side effects of platinum-based chemotherapy drugs: a review for chemists
Rabbab Oun et al.
DALTON TRANSACTIONS (2018)
Sodium-dependent Vitamin C transporter 2 deficiency impairs myelination and remyelination after injury: Roles of collagen and demethylation
Dominik Roehr et al.
GLIA (2017)
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights
Paola Marmiroli et al.
PLOS ONE (2017)
Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes
Ben W. Johnson et al.
BMC CANCER (2016)
Long-Term Renal Outcomes after Cisplatin Treatment
Sheron Latcha et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Non-Transgenic Mouse Models of Kidney Disease
Michael Rabe et al.
NEPHRON (2016)
Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles
Christopher G. England et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions
Navjotsingh Pabla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Role of transporters in the distribution of platinum-based drugs
Saliha Harrach et al.
FRONTIERS IN PHARMACOLOGY (2015)
Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
Jason A. Sprowl et al.
CLINICAL CANCER RESEARCH (2014)
The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3
Vivian Massmann et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
Precise Comparison of Protein Localization Among OCT, OAT, and MATE in Human Kidney
Hideyuki Motohashi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
Rossella Marullo et al.
PLOS ONE (2013)
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
Jason A. Sprowl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™)
A. Canta et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Oxaliplatin Transport Mediated by Organic Cation/Carnitine Transporters OCTN1 and OCTN2 in Overexpressing Human Embryonic Kidney 293 Cells and Rat Dorsal Root Ganglion Neurons
Nancy N. Jong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
Giuliano Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies
V. A. Carozzi et al.
EXPERIMENTAL NEUROLOGY (2010)
The rat caudal nerves: a model for experimental neuropathies
Herbert H. Schaumburg et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity
Johnson J. Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Calmodulin-associated post-translational regulation of rat organic cation transporter 2 in the kidney is gender dependent
S. Wilde et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
K. K. Filipski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)
Atsushi Yonezawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat
A Yonezawa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2
G Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation
G Ciarimboli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease
C Popp et al.
MOLECULAR PHARMACOLOGY (2005)
Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity
ES McDonald et al.
NEUROBIOLOGY OF DISEASE (2005)
Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations
JW Jonker et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Curing metastatic testicular cancer
LH Einhorn
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
